These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23521104)

  • 1. Bioresorbable polymersomes for targeted delivery of cisplatin.
    Petersen MA; Hillmyer MA; Kokkoli E
    Bioconjug Chem; 2013 Apr; 24(4):533-43. PubMed ID: 23521104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    Shroff K; Kokkoli E
    Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon Orai3 protein expression.
    Pangburn TO; Georgiou K; Bates FS; Kokkoli E
    Langmuir; 2012 Sep; 28(35):12816-30. PubMed ID: 22827285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride.
    Du Y; Chen W; Zheng M; Meng F; Zhong Z
    Biomaterials; 2012 Oct; 33(29):7291-9. PubMed ID: 22795540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and in vivo evaluation of a magnetic cisplatin delivery nanosystem based on PMAA-graft-PEG copolymers.
    Voulgari E; Bakandritsos A; Galtsidis S; Zoumpourlis V; Burke BP; Clemente GS; Cawthorne C; Archibald SJ; Tuček J; Zbořil R; Kantarelou V; Karydas AG; Avgoustakis K
    J Control Release; 2016 Dec; 243():342-356. PubMed ID: 27793687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
    Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
    Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
    Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
    Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S
    Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery.
    Smitha KT; Anitha A; Furuike T; Tamura H; Nair SV; Jayakumar R
    Colloids Surf B Biointerfaces; 2013 Apr; 104():245-53. PubMed ID: 23337120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line.
    Ruiz-Gómez MJ; de la Peña L; Prieto-Barcia MI; Pastor JM; Gil L; Martínez-Morillo M
    Bioelectromagnetics; 2002 Dec; 23(8):578-85. PubMed ID: 12395412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.
    Garg A; Kokkoli E
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1135-43. PubMed ID: 21470144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon Cancer and Specific Ways to Deliver Drugs to the Large Intestine.
    Derakhshankhah H; Izadi Z; Alaei L; Lotfabadi A; Saboury AA; Dinarvand R; Divsalar A; Seyedarabi A; Barzegari E; Evini M
    Anticancer Agents Med Chem; 2017; 17(10):1317-1327. PubMed ID: 28270073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible functionalization of polymersome surfaces: a new approach to surface immobilization and cell targeting using polymersomes.
    Egli S; Nussbaumer MG; Balasubramanian V; Chami M; Bruns N; Palivan C; Meier W
    J Am Chem Soc; 2011 Mar; 133(12):4476-83. PubMed ID: 21370858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
    Lin CH; Cheng SH; Liao WN; Wei PR; Sung PJ; Weng CF; Lee CH
    Int J Pharm; 2012 Jun; 429(1-2):138-47. PubMed ID: 22465413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable polymersomes with an ionizable membrane: facile preparation, superior protein loading, and endosomal pH-responsive protein release.
    Li S; Meng F; Wang Z; Zhong Y; Zheng M; Liu H; Zhong Z
    Eur J Pharm Biopharm; 2012 Sep; 82(1):103-11. PubMed ID: 22691417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin.
    Moreno D; Zalba S; Colom H; Trocóniz IF; Tros de Ilarduya C; Garrido MJ
    Eur J Pharm Sci; 2009 Jun; 37(3-4):341-50. PubMed ID: 19491025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.